Dr. Schachter specializes in ocular surface disease and serves as a Vision Source administrator for central California coast. He serves on the advisory board for Allergan, BlephEx, Sun Pharma, and ScienceBased Health, and he is a speaker for Allergan, Bau

, reviews Oxervate, the first FDA-approved treatment for neurotrophic keratitis to exhibit complete corneal healing.

News

Test

Practice Management

Blog

There is treatment hope for neurotrophic keratitis, a rare disease affecting the cornea. 

How one OD uses Oxervate for corneal healing

Latest News